Rivastigmine

Pronunciation

Rivastigmine 1.5mg (EXELON 1.5mg)

Rivastigmine 3mg (EXELON 3mg)

Rivastigmine 4.5mg (EXELON 4.5mg)

Introduction

Rivastigmine, is a reversible acetylcholinesterase inhibitor. Rivastigmine is selective for the CNS and is used for the treatment of mild to moderate dementia associated with Parkinson’s disease.

Mechanism of Action

Acetylcholinesterase inhibiting drug

Generic Name 藥名	HA Code 藥物代碼	Classification藥物分類
Rivastigmine Cap 1.5 mg	RIVA01	P1S1S3
Rivastigmine Cap 3 mg	RIVA02	P1S1S3
Rivastigmine Cap 6 mg	RIVA04	P1S1S3

Dosage

The drug can be administered orally or via a transdermal patch; the latter form reduces the prevalence of side effects, which typically include nausea and vomiting.

By Oral: initially 1.5 mg twice daily, increased in steps of 1.5 mg twice daily at intervals of at least 2 weeks according to response and tolerance. Usual range 3-6 mg twice daily. Maximum 6 mg twice daily. If treatment interrupted for more than several days, treatment should be retitrated from 1.5 mg twice daily.

Transdermal patches delivering 4.6, 9.5, or 13.3 mg of rivastigmine over 24 hours are also available for once-daily application.

Transdermal application: initially apply 4.6 mg/24 hours patch to clean, dry, non-hairy, non-irritated skin on back, upper arm, or chest, removing after 24 hours. It should not be applied to the abdomen or thigh due to decreased bioavailability. Re-application to the same site should be avoided for 14 days. Only one patch should be applied at a time.

If well tolerated, increase to 9.5 mg/24 hours patch daily.